Mindfulness to Enhance Quality of Life and Support Advance Care Planning
MEANING
1 other identifier
interventional
108
1 country
1
Brief Summary
The MEANING trial is a randomized controlled mixed methods pilot designed to compare a novel mindfulness meditation-based intervention (MEANING) to usual care for adults with advanced-stage solid malignancies and their family caregivers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 9, 2017
CompletedFirst Submitted
Initial submission to the registry
August 16, 2017
CompletedFirst Posted
Study publicly available on registry
August 22, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 11, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 11, 2017
CompletedAugust 12, 2020
August 1, 2020
7 months
August 16, 2017
August 10, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Change from baseline in quality of life (QoL) for Patients
QoL for patients will be assessed with the McGill Quality of Life Inventory.
Baseline, 6 weeks, and 10 weeks
Change from baseline in quality of life (QoL) for Family Caregivers
QoL for family caregivers will be assessed with the Caregiver Quality of Life - Cancer scale (CQoLC).
Baseline, 6 weeks, and 10 weeks
Secondary Outcomes (15)
Change from baseline in advance care planning (ACP) stage of change
Baseline, 6 weeks, and 10 weeks
Change from baseline in advance care planning (ACP) engagement
Baseline, 6 weeks, and 10 weeks
Change from baseline in caregiver burden
Baseline, 6 weeks, and 10 weeks
Change from baseline in avoidant coping
Baseline, 6 weeks, and 10 weeks
Change from baseline in avoidant coping
Baseline, 6 weeks, and 10 weeks
- +10 more secondary outcomes
Study Arms (2)
Usual Care
NO INTERVENTIONParticipants assigned to Usual Care will continue to receive standard care from their oncology team, including access to supportive care from oncology social workers. At the end of the study, usual care dyads will receive a packet of informational materials on mindfulness meditation, receive a CD with 5 mindfulness meditation practices, and meet with the study interventionist for guidance on how to use the materials and mindfulness recordings to their advantage in coping with cancer-related challenges.
Mindfulness
ACTIVE COMPARATORThe Mindfulness intervention will consist of six 2-hour sessions that will include guided mindfulness practices, didactics, and group discussion. The course curriculum is modeled on the Mindfulness-Based Stress Reduction program which involves intensive experiential training of participants in secular mindfulness meditation practices (i.e., body scan, sitting meditation, gentle hatha yoga with chair adaptations, compassion meditation), with an emphasis on embodying interpersonal mindfulness in dialogue.
Interventions
The Mindfulness intervention sessions are designed to cultivate present-moment awareness in everyday life to facilitate adaptive and non-reactive relating to thoughts, feelings, and bodily sensations. Participants will be provided with 10-20 minute audio recordings of each of 5 mindfulness practices covered in class, recorded in the facilitator's voice. Participants will be encouraged to practice mindfulness at home 10-20 minutes per day, 6 days per week. Participants will be provided with weekly diaries on which to record type and amount of home practice of mindfulness skills.
Eligibility Criteria
You may qualify if:
- Patient is at least 18 years of age.
- Patient is at least 3 weeks post-diagnosis of an incurable (locally advanced or metastatic) solid malignancy.
- Patient's attending medical oncologist would not be surprised if the patient died in the next 12 months.
- Patient has not completed a POST form.
- Patient scores ≥ 7 on the Mini-Mental Adjustment to Cancer cognitive avoidance subscale.
- Patient is willing and able to consent and travel to the class location for 6 weekly 2-hour sessions.
- Patient has a family member or close friend eligible and interested in participating in the study.
- Patient has adequate English fluency for completion of data collection
- FCG is at least 18 years of age.
- FCG has been invited to participate in the trial with a patient who meets eligibility criteria above.
- FCG is willing and able to consent and travel to the class location for 6 weekly 2-hour sessions.
- FCG has adequate English fluency for completion of data collection
You may not qualify if:
- Patient reports a score of \> 2 on the Activities and Function item from the Patient Generated Subjective Global Assessment91 (PG-SGA; the patient-reported version of the Eastern Cooperative Oncology Group score).
- Patient makes 3 or more errors on a validated 6-item cognitive screener or exhibits significant psychiatric or cognitive impairment (e.g., dementia/delirium, retardation, active psychosis) that in the judgment of the investigators would preclude providing informed consent and study participation.
- Currently receiving hospice care (patients who enroll in hospice during the trial will have the option of continuing trial participation).
- FCG exhibits significant psychiatric or cognitive impairment (e.g., dementia/delirium, retardation, active psychosis) that in the judgment of the investigators would preclude providing informed consent and study participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Indiana University
Indianapolis, Indiana, 46202, United States
Related Publications (1)
Mosher CE, Beck-Coon KA, Wu W, Lewson AB, Stutz PV, Brown LF, Tang Q, Helft PR, Levoy K, Hickman SE, Johns SA. Mindfulness to enhance quality of life and support advance care planning: a pilot randomized controlled trial for adults with advanced cancer and their family caregivers. BMC Palliat Care. 2024 Sep 28;23(1):232. doi: 10.1186/s12904-024-01564-7.
PMID: 39342143DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shelley A Johns, PsyD
Indiana University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Participants are blind to study hypotheses.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Medicine, Research Scientist
Study Record Dates
First Submitted
August 16, 2017
First Posted
August 22, 2017
Study Start
May 9, 2017
Primary Completion
December 11, 2017
Study Completion
December 11, 2017
Last Updated
August 12, 2020
Record last verified: 2020-08